Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Circadia Health develops AI-powered, FDA-cleared contactless remote monitoring devices (C100, C200) for continuous, unsupervised measurement of respiratory rate, heart rate, motion, and bed exits in senior care settings. Their system integrates with Electronic Health Records (EHR) and delivers predictive analytics, enabling early intervention and reducing 30-day preventable rehospitalizations by ~25%. Clinically validated studies have shown the C100 System can predict clinical deterioration up to 24 hours in advance, improving outcomes in skilled nursing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Circadia Health.